Russell Cox is President, Chief Executive Officer and a member of the Board of Directors of Epirium Bio. Russell also serves on the Board of Directors of Gossamer Bio. Previously, he served as Chief Executive Officer and a member of the Board of Directors at Vital Therapies. He also formerly served as Executive Vice President and Chief Operating Officer of Jazz Pharmaceuticals. As COO he held responsibility for the company’s Commercial, R&D, Manufacturing, International, and Global Molecule Leadership teams. He worked in a variety of escalating senior management roles from 2010 to 2018, including Executive Vice President and Chief Commercial Officer from March 2012 to May 2014. From January 2009 to January 2010, he was Senior Vice President and Chief Commercial Officer of Ipsen Group, and from 2007 until December 2008 he was Vice President of Marketing at Tercica, Inc., a biotechnology company acquired by Ipsen Group. From 2003 to 2007, he was with Scios, Inc. (acquired by Johnson & Johnson in 2003), where he served as Vice President of Marketing. Prior to 2003, Russell was with Genentech, Inc. for 12 years, where he was a Product Team Leader responsible for the company’s growth hormone franchise and led numerous product launches as a group product manager. Russell received a B.S. in biomedical science from Texas A&M University.